Long noncoding RNAs and their possible roles in tumorigenesis and drug resistance in cancer chemotherapy

• Published in: Nucleosides, nucleotides & nucleic acids pp. 1 - 15
• Main Authors: Ali, Ehsan Sayed, Yalın, Ali Erdinç, Yalın, Serap
• Format: Journal Article
• Language: English
• Published: United States 04.04.2024
• Subjects: chemotherapy resistance; tumor formation process; LncRNAs
• ISSN: 1525-7770; 1532-2335
• DOI: 10.1080/15257770.2024.2336210

Cancer is still one of the most important diseases that have a high mortality rate around the world. The management of cancer involves many procedures, which include surgery, radiotherapy, and chemotherapy. Drug resistance in cancer chemotherapy is considered one of the most important problems in clinical oncology. A good understanding of the tumorigenesis process and the mechanisms of developing chemotherapy resistance in cancer cells will help achieve significant advances in cancer treatment protocols. In recent years, there has been an increasing interest in long noncoding RNAs (lncRNAs). LncRNAs are no longer just a transcriptional noise, and many investigations proved their possible roles in regulating mandatory cellular functions. A lot of newly published studies confirmed the implication of lncRNAs in the tumor formation process and the multiple drug resistance in cancer chemotherapy. The main aim of this review is to focus on the lncRNAs' functions in the cell, their possible roles in the tumor formation process, and their roles in the development of chemotherapy resistance in different cancer cells.